The Proton Pump Inhibitors (PPIs) market refers to the global pharmaceutical market for drugs that reduce stomach acid production by inhibiting the gastric proton pump a key treatment for acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and related conditions.